Showing 1 - 5 results of 5 for search 'WILL Trial Study Group', query time: 0.08s Refine Results
  1. 1
    Blood absolute lymphocyte count and trajectory are important in understanding severe COVID-19

    Blood absolute lymphocyte count and trajectory are important in understanding severe COVID-19 by Catharine I. Paules, Jacqueline A. Nordwall, Kathryn Shaw-Saliba, Judith A. Aberg, Edward M. Gardner, Anna L. Goodman, N. Kumarasamy, Shikha Vasudeva, David M. Vock, Crystal M. North, Jens Lundgren, Neil R. Aggarwal, for the STRIVE Network and TICO Trial Study Group

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Long-term biological and behavioural impact of an adolescent sexual health intervention in Tanzania: follow-up survey of the community-based MEMA kwa Vijana Trial.

    Long-term biological and behavioural impact of an adolescent sexual health intervention in Tanzania: follow-up survey of the community-based MEMA kwa Vijana Trial. by Aoife M Doyle, David A Ross, Kaballa Maganja, Kathy Baisley, Clemens Masesa, Aura Andreasen, Mary L Plummer, Angela I N Obasi, Helen A Weiss, Saidi Kapiga, Deborah Watson-Jones, John Changalucha, Richard J Hayes, MEMA kwa Vijana Trial Study Group

    Published 2010-06-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Determining optimal timing of birth for women with chronic or gestational hypertension at term: The WILL (When to Induce Labour to Limit risk in pregnancy hypertension) randomised trial.

    Determining optimal timing of birth for women with chronic or gestational hypertension at term: The WILL (When to Induce Labour to Limit risk in pregnancy hypertension) randomised... by Laura A Magee, Katie Kirkham, Sue Tohill, Eleni Gkini, Catherine A Moakes, Jon Dorling, Marcus Green, Jennifer A Hutcheon, Mishal Javed, Jesse Kigozi, Ben W M Mol, Joel Singer, Pollyanna Hardy, Clive Stubbs, James G Thornton, Peter von Dadelszen, WILL Trial Study Group

    Published 2024-11-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Correction: Determining optimal timing of birth for women with chronic or gestational hypertension at term: The WILL (When to Induce Labour to Limit risk in pregnancy hypertension) randomised trial.

    Correction: Determining optimal timing of birth for women with chronic or gestational hypertension at term: The WILL (When to Induce Labour to Limit risk in pregnancy hypertension)... by Laura A Magee, Katie Kirkham, Sue Tohill, Eleni Gkini, Catherine A Moakes, Jon Dorling, Marcus Green, Jennifer A Hutcheon, Mishal Javed, Jesse Kigozi, Ben W M Mol, Joel Singer, Pollyanna Hardy, Clive Stubbs, James G Thornton, Peter von Dadelszen, WILL Trial Study Group

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Recognition and management of community-acquired acute kidney injury in low-resource settings in the ISN 0by25 trial: A multi-country feasibility study.

    Recognition and management of community-acquired acute kidney injury in low-resource settings in the ISN 0by25 trial: A multi-country feasibility study. by Etienne Macedo, Ulla Hemmila, Sanjib Kumar Sharma, Rolando Claure-Del Granado, Henry Mzinganjira, Emmanuel A Burdmann, Jorge Cerdá, John Feehally, Fredric Finkelstein, Guillermo García-García, Vivekanand Jha, Norbert H Lameire, Euyhyun Lee, Nathan W Levin, Andrew Lewington, Raúl Lombardi, Michael V Rocco, Eliah Aronoff-Spencer, Marcello Tonelli, Karen Yeates, Giuseppe Remuzzi, Ravindra L Mehta, ISN 0by25 Trial Study Group

    Published 2021-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: